Scinai Immunotherapeutics Ltd.

SCNI · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$5-$7-$6-$8
Dep. & Amort.$2$1$1$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$1$2$3
Change in WC$0-$1$0$1
Other Non-Cash-$14-$4-$4-$3
Operating Cash Flow-$6-$9-$7-$7
Investing Activities
PP&E Inv.-$0-$1-$1-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$1-$1-$0
Financing Activities
Debt Repay.$0$0$0-$0
Stock Issued$2$0$7$21
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$1$0$0
Financing Cash Flow$3$1$7$21
Forex Effect-$0-$0-$2$1
Net Chg. in Cash-$3-$9-$3$14
Supplemental Information
Beg. Cash$5$14$18$3
End Cash$2$5$14$18
Free Cash Flow-$6-$10-$8-$8
Scinai Immunotherapeutics Ltd. (SCNI) Financial Statements & Key Stats | AlphaPilot